We are live on
!
Find out more
GP
GLG Partners Portfolio holdings
AUM
$2.14B
1-Year Est. Return
21.14%
This Fund
S&P 500
This Quarter
Est. Return
+5.42%
1 Year Est. Return
+21.14%
3 Year Est. Return
+49.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.14B
AUM Growth
+$251M
(+13%)
Cap. Flow
-$130M
Cap. Flow
% of AUM
-6.09%
Top 10 Holdings %
Top 10 Hldgs %
20.07%
Holding
564
New
243
Increased
78
Reduced
76
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AAAP
Advanced Accelerator Applications S.A.
AAAP
|
+$46.8M |
| 2 |
NXP Semiconductors
NXPI
|
+$35M |
| 3 |
MON
Monsanto Co
MON
|
+$29.2M |
| 4 |
CYOU
Changyou.com Limited American Depositary Share
CYOU
|
+$22.9M |
| 5 |
Dell
DELL
|
+$22.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCLN
Sciclone Pharmaceuticals Inc
SCLN
|
+$29M |
| 2 |
RICE
Rice Energy Inc.
RICE
|
+$23M |
| 3 |
Criteo S.A.
CRTO
|
+$22.5M |
| 4 |
BCR
CR Bard Inc.
BCR
|
+$18M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$15.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.22% |
| 2 | Consumer Discretionary | 13.47% |
| 3 | Technology | 9.7% |
| 4 | Financials | 9.51% |
| 5 | Industrials | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Globe Life
GL
$13.4B
| $26K | ﹤0.01% |
+290
| New | +$24.9K |
|
402
Nasdaq
NDAQ
$54.2B
| $26K | ﹤0.01% |
+1,005
| New | +$25.4K |
|
403
Chipotle Mexican Grill
CMG
$46.8B
| $23K | ﹤0.01% |
+4,050
| New | +$24.2K |
|
404
NiSource
NI
$19.8B
| $23K | ﹤0.01% |
+915
| New | +$24.3K |
|
405
Kimco Realty
KIM
$15.8B
| $22K | ﹤0.01% |
+1,228
| New | +$23K |
|
406
Becton Dickinson
BDX
$50.3B
| $21K | ﹤0.01% |
+99
| New | +$20.7K |
|
|
ESRX
407
DELISTED
Express Scripts Holding Company
ESRX
| $20K | ﹤0.01% |
+267
| New | +$17.1K |
|
|
GRMN
408
Garmin
GRMN
$53.4B
| $18K | ﹤0.01% |
300
-4,914
| -94% | -$288K |
|
|
BIVV
409
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $4K | ﹤0.01% |
+71
| New | +$3.88K |
|
410
Henry Schein
HSIC
$10B
| $3K | ﹤0.01% |
+47
| New | +$2.73K |
|
411
Advance Auto Parts
AAP
$2.67B
| $1K | ﹤0.01% |
12
-39,838
| -100% | -$3.66M |
|
412
CALL
Alcoa
AA
$13.2B
| – | – |
-644,600
| Closed | -$30.1M |
|
413
American Airlines Group
AAL
$8.69B
| – | – |
-6,722
| Closed | -$319K |
|
414
Abbott
ABT
$187B
| – | – |
-10,000
| Closed | -$534K |
|
415
Antero Resources
AR
$12.1B
| – | – |
-37,688
| Closed | -$750K |
|
416
CALL
Bank of America
BAC
$438B
| – | – |
-44,700
| Closed | -$1.13M |
|
|
417
Bank of America
BAC
$438B
| – | – |
-18,800
| Closed | -$476K |
|
418
Best Buy
BBY
$19B
| – | – |
-50,987
| Closed | -$2.9M |
|
419
Citigroup
C
$231B
| – | – |
-7,414
| Closed | -$539K |
|
420
Caleres
CAL
$418M
| – | – |
-80,497
| Closed | -$2.46M |
|
421
Chemours
CC
$2.3B
| – | – |
-11,638
| Closed | -$589K |
|
422
Cameco
CCJ
$43.9B
| – | – |
-74,579
| Closed | -$721K |
|
423
Charter Communications
CHTR
$18.1B
| – | – |
-447
| Closed | -$162K |
|
424
Cigna
CI
$74.7B
| – | – |
-5,000
| Closed | -$935K |
|
425
Cenovus Energy
CVE
$59.7B
| – | – |
-39,770
| Closed | -$398K |
|
Similar funds
IH
GL
TAM
SI
GES
AS
QAM
BTIS
GLG Partners's Q4 2017 Portfolio in Review
As of Q4 2017, GLG Partners held 564 positions worth $2.14B, up 13% from $1.89B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
GLG Partners withdrew a net $130M in Q4 2017, closing 91 positions and reducing 76 holdings. Its most notable exit was Sciclone Pharmaceuticals Inc, an estimated $29M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, GLG Partners opened a new position in Advanced Accelerator Applications S.A. worth $49.2M.
- GLG Partners's largest Q4 2017 buy was Advanced Accelerator Applications S.A.: 603,055 shares worth $49.2M.
- GLG Partners added most to NXP Semiconductors in Q4 2017, an estimated $35M increase.
- GLG Partners's biggest Q4 2017 reduction was Criteo S.A., cutting an estimated $22.5M.
- GLG Partners fully exited Sciclone Pharmaceuticals Inc in Q4 2017, selling an estimated $29M.
- GLG Partners's ten largest holdings make up 20% of its $2.14B portfolio in Q4 2017.
- GLG Partners opened 243 new positions and closed 91 in Q4 2017.
- GLG Partners's portfolio value rose 13% quarter-over-quarter to $2.14B.
Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.